In the 1980s, after decades of steadily declining rates of tuberculosis, ambitious plans were
made to eliminate the disease in the United States. Despite these plans, the control of …

Background Treatment of latent infection is needed to protect HIV-infected individuals
against tuberculosis. A previous report addressed short-term efficacy of three regimens in …

Objective To determine the long-term effect of preventive therapy (PT) for tuberculosis on the
rates of tuberculosis, mortality and HIV progression. Methods In a randomized controlled …

PURPOSE: To determine the effect of several interventions on adherence to tuberculosis
preventive therapy. Methods: We conducted a randomized trial with a factorial design …

The burden of human immunodeficiency virus (HIV)-related disease in sub-Saharan Africa
continues to increase; providing adequate care for the huge number of people affected is a …

This issue of the Journal includes a report from the Centers for Disease Control and
Prevention (CDC) of 21 cases of serious hepatotoxicity, including 5 deaths, attributed to …

This study examined whether costs associated with tuberculosis (TB) screening and directly
observed preventive therapy (DOPT) among drug injectors attending a syringe exchange …

The aim of this study was to assess the degree of implementation of national guidelines for
isoniazid preventive therapy (IPT) among human immunodeficiency virus (HIV)-infected …

Large populations of dendritic cells (DCs) are found throughout the respiratory tract, the
most prominent comprising a contiguous network dispersed throughout the epithelium and …

Tuberculosis and HIV have combined to present a major threat to global public health. Each
disease has a negative effect on the other, and mortality in patients with both tuberculosis …